Ascrinvacumab (Anti-ACVRL1 / ALK-1)
Product Specifications
CAS Number
1463459-96-2
Synonyms
PF-03446962
Target
ALK
Applications
Protein Tyrosine Kinase
Additionnal Information
Ascrinvacumab (Anti-ACVRL1 / ALK-1) is a human IgG2 monoclonal antibody targeting ALK-1. It can be used for the treatment of hepatocellular carcinoma (HCC), in patients with advanced solid tumors. It also demonstrates its use in antiangiogenic therapy. MW : 150 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC880253-500 1x 500 µL
Cytokeratin, LMW (AE-1), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880266-500 1x 500 µL
Human IgG Immunoglobulin (IG266), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC681037-100 1x 100 µL
CD44 Standard (DF1485), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details